Alliancebernstein L.P. Raises Position in Imperva Inc (IMPV)

Alliancebernstein L.P. increased its stake in shares of Imperva Inc (NYSE:IMPV) by 16.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 55,950 shares of the software maker’s stock after acquiring an additional 8,100 shares during the quarter. Alliancebernstein L.P. owned about 0.17% of Imperva worth $2,677,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of IMPV. Ameritas Investment Partners Inc. bought a new position in Imperva during the first quarter valued at $102,000. Principal Financial Group Inc. bought a new position in Imperva during the second quarter valued at $223,000. KCG Holdings Inc. bought a new position in Imperva during the first quarter valued at $201,000. Turner Investments LLC bought a new position in Imperva during the second quarter valued at $239,000. Finally, US Bancorp DE lifted its position in Imperva by 142.3% during the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock valued at $221,000 after purchasing an additional 3,163 shares during the last quarter. Hedge funds and other institutional investors own 92.72% of the company’s stock.

Imperva Inc (NYSE IMPV) opened at 43.50 on Friday. The company has a 50-day moving average of $44.05 and a 200 day moving average of $45.81. The stock’s market cap is $1.47 billion. Imperva Inc has a 1-year low of $34.40 and a 1-year high of $52.40.

Imperva (NYSE:IMPV) last announced its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.15). The firm had revenue of $74.44 million for the quarter, compared to analyst estimates of $74.30 million. Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The company’s revenue was up 28.6% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.23) EPS. Analysts predict that Imperva Inc will post $0.81 EPS for the current year.

Several equities analysts have commented on the stock. ValuEngine lowered shares of Imperva from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Stifel Nicolaus reiterated a “hold” rating and set a $47.00 price objective on shares of Imperva in a research report on Friday, July 14th. Imperial Capital lowered their price objective on shares of Imperva from $57.00 to $50.00 and set an “outperform” rating for the company in a research report on Tuesday. BidaskClub upgraded shares of Imperva from a “sell” rating to a “hold” rating in a research report on Tuesday, September 12th. Finally, Stephens reiterated an “overweight” rating and set a $61.00 price objective (up previously from $53.00) on shares of Imperva in a research report on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $52.34.

In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the transaction, the director now owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.20% of the company’s stock.

WARNING: This news story was published by Markets Daily and is the sole property of of Markets Daily. If you are accessing this news story on another site, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.themarketsdaily.com/2017/10/13/alliancebernstein-l-p-raises-position-in-imperva-inc-impv.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva Inc (NYSE:IMPV).

Institutional Ownership by Quarter for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply